🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
Ultragenyx Pharmaceutical Inc. (RARE)
NASDAQ: RARE · Real-Time Price · USD
16.48
-0.74 (-4.30%)
At close: Nov 20, 2026, 4:00 PM EST
16.50
+0.02 (0.12%)
After-hours: Nov 20, 2026, 7:31 PM EST

Ultragenyx Pharmaceutical Revenue

Ultragenyx Pharmaceutical had revenue of $173.00M in the quarter ending September 30, 2026, with 8.13% growth. This brings the company's total for the last twelve months to $730.00M, up 15.75% year-over-year. In the year 2025, Ultragenyx Pharmaceutical had annual revenue of $673.00M with 20.18% growth. That makes Ultragenyx Pharmaceutical the 9,202nd largest company in the world by revenue and 2,040th in the United States.

Revenue (ttm)
$730.00M
Revenue Growth
+15.75%
P/S Ratio
2.29
Revenue / Employee
$532,458
Employees
1,371
Market Cap
1.67B

Revenue Chart

Revenue by Segment

By Segment

Chart
  • Crysvita Royalty 304.00M 45.2%
  • Crysvita 177.00M 26.3%
  • Dojolvi 96.00M 14.3%
  • Evkeeza 59.00M 8.8%
  • Mepsevii 37.00M 5.5%

By Geography

Chart
  • North America 377.00M 56.0%
  • Latin America 170.00M 25.3%
  • Europe 108.00M 16.0%
  • Asia-Pacific 18.00M 2.7%

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2025673.00M113.00M20.18%
Dec 31, 2024560.00M126.00M29.03%
Dec 31, 2023434.00M70.67M19.45%
Dec 31, 2022363.33M11.92M3.39%
Dec 31, 2021351.41M80.38M29.66%
Dec 31, 2020271.03M167.32M161.32%
Dec 31, 2019103.71M52.22M101.41%
Dec 31, 201851.50M48.88M1,871.48%
Dec 31, 20172.61M2.48M1,863.91%
Dec 31, 2016133.00K--
Dec 31, 2015---
Dec 31, 2014---
Dec 31, 2013---
Dec 31, 2012---
Dec 31, 2011---